Anoikis
Anoikis is a form of programmed cell death that occurs in anchorage-dependent cells when they detach from the surrounding extracellular matrix (ECM). This process is significant in tissue homeostasis and development. Anoikis resistance is a critical factor in cancer metastasis.
Overview[edit]
Anoikis is a Greek word meaning "homelessness". It was first described in 1994 by Frisch and Francis. The term is used to describe the process where cells undergo apoptosis when they lose contact with the extracellular matrix (ECM) or neighboring cells. This is a crucial mechanism in preventing detached cells from colonizing elsewhere in the organism, thus preventing the spread of cancer cells.
Mechanism[edit]
The mechanism of anoikis is complex and involves several pathways. The main pathway is the integrin-mediated survival signals. When cells detach from the ECM, the integrin signals are lost, leading to the activation of caspase enzymes and cell death. Other pathways include the Epidermal Growth Factor Receptor (EGFR) pathway and the Hippo pathway.
Role in Cancer[edit]
Anoikis resistance is a hallmark of cancer cells. Cancer cells can resist anoikis and survive after detachment from the ECM. This allows them to metastasize and colonize distant organs. Understanding the mechanisms of anoikis and anoikis resistance is crucial for the development of new cancer therapies.
See Also[edit]
- Apoptosis
- Cancer metastasis
- Extracellular matrix
- Integrin
- Caspase
- Epidermal Growth Factor Receptor
- Hippo pathway
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
